Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection

BACKGROUND: Little is known about the risk of hepatitis B virus (HBV) reactivation in patients receiving interferon (IFN)-free direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV). METHODS: Patients who were seropositive for HBV core antibody and who received IFN-free DAAs for HCV were...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chen-Hua, Liu, Chun-Jen, Su, Tung-Hung, Fang, Yu-Jen, Yang, Hung-Chih, Chen, Pei-Jer, Chen, Ding-Shinn, Kao, Jia-Horng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414056/
https://www.ncbi.nlm.nih.gov/pubmed/28480296
http://dx.doi.org/10.1093/ofid/ofx028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414056/
https://www.ncbi.nlm.nih.gov/pubmed/28480296
http://dx.doi.org/10.1093/ofid/ofx028

Ejemplares similares